The spectrum of chronic inflammatory demyelinating polyneuropathy

Journal of the Neurological Sciences

Volumn 173, Issue 2, 2000, Pages 129-139

  Rotta, Francisco T ^a   Sussman, Alyssa T ^a   Bradley, Walter G ^a   Ram Ayyar, D ^a   Sharma, Khema R ^a   Shebert, Robert T ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Demyelination; Electrophysiology; Immunosuppressive treatment; Polyneuropathy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; CRANIAL NEUROPATHY; DEMYELINATING DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MOTOR NERVE; PHENOTYPE; POLYNEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SCHOOL CHILD; SENSORY NERVE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; BIOPSY; BLOOD PROTEIN ELECTROPHORESIS; CEREBROSPINAL FLUID PROTEINS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CRANIAL NERVES; DIABETIC NEUROPATHIES; ELECTROPHYSIOLOGY; FEMALE; FLORIDA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PARAPROTEINEMIAS; PERIPHERAL NERVES; PHENOTYPE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RETROSPECTIVE STUDIES; SPINAL CORD; TREATMENT FAILURE;

EID: 0034651624     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00317-2     Document Type: Article

References (37)

1. Austin J.H. Recurrent polyneuropathies and their corticosteroid treatment. Brain. 81:1958;11-192.
2. Barohn R.J., Kissel J.T., Warmolts J.R., Mendell J.R. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics and recommendation for diagnostic criteria. Arch. Neurol. 46:1989;878-884.
3. Cornblath D.R., Asbury A.K., Albers J.W., Feasby T.E., Hahn A.F., McLeod J.G., et al. Report from an Ad Hoc Subcommitee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 41:1991;617-618.
4. Bosch E.P., Mitsumoto H. Disorders of peripheral nerves. Bradley W.G., Daroff R.B., Fenichel G.M., Marsden C.D., Neurology in clinical practice. 2nd ed. 1996;1881-1952 Butterworth-Heinemann, Boston.
5. Kimura J. Facts, fallacies and fancies of nerve conduction studies: twenty-first annual Edward H. Lambert lecture. Muscle Nerve. 20:1997;777-787.
6. Rhee E.K., England J.D., Summer A.J. A computer simulation of conduction block: effects produced by actual block versus interphase cancellation. Ann. Neurol. 28:1990;146-156.
7. Dyck P.J., Swanson P.A., Low P.A., Bartleson J.D., Lambert E.H. Prednisone responsive hereditary motor and sensory neuropathy. Mayo Clin. Proc. 57:1982;239-246.
8. Rotta F.T., Bradley W.G. Marked improvement of severe polyneuropathy associated with multifocal osteosclerotic myeloma following surgery, radiation, and chemotherapy. Muscle Nerve. 20:1997;1035-1037.
9. Dyck P.J., Lais A.C., Ohta M., Bastron J.A., Okazaki H., Groover R.V. Chronic inflammatory polyradiculoneuropathy. Mayo Clin. Proc. 50:1975;621-637.
10. McCombe P.A., Pollard J.D., McLeod J.G. Chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and electrophysiological study of 92 cases. Brain. 110:1987;1617-1630.
11. Simmons Z., Albers J.W., Broomberg M.B., Feldman E.L. Long term follow up of patients with chronic inflammatory demyelinating polyneuropathy with or without monoclonal gammopathy. Brain. 118:1995;359-368.
12. Maisonobe T., Chassande B., Verin M., Jouni M., Leger J.M., Bouche P. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. J. Neurol. Neurosurg. Psychiatry. 61:1996;36-42.
13. Gorson C.G., Allam G., Ropper A.H. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology. 48:1997;321-328.
14. Concha M., Romano J.G., Rotta F.T., Potter P., Schwartzbard J., Koch S., et al. Description of a neurology outpatient clinic at a county hospital in Miami, and its suitability for residency training in ambulatory care. Neuroepidemiol. 15:1996;17.
15. Oh S.J., Joy J.L., Kuruoglu R. Chronic sensory demyelinating neuropathy: chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J. Neurol. Neurosurg. Psychiatry. 55:1992;677-680.
16. Cros D., Chiappa K.H., Patel S., Gominak S. Acquired pure sensory demyelinating neuropathy: a chronic inflammatory demyelinating polyradiculoneuropathy variant? Ann. Neurol. 32:1992;280.
17. Berger A.R., Herskovitz S., Kaplan J. Late motor involvement in cases presenting as chronic sensory demyelinating polyneuropathy. Muscle Nerve. 18:1995;440-444.
18. Smith T.S. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinemia: a clinical and neurophysiological study. Brain. 117:1994;949-957.
19. Bradley W.G., Bennet R.K., Good P., Little B. Proximal chronic inflammatory polyneuropathy with multifocal conduction block. Arch. Neurol. 45:1988;451-455.
20. Verma A., Tandan R., Adesina A.M., Pendlebury W.W., Fries T.J., Bradley W.G. Focal neuropathy preceding chronic inflammatory demyelinating polyradiculoneuropathy by several years. Acta Neurol. Scand. 81:1990;516-521.
21. Verma A., Bradley W.G. High-dose intravenous immunoglobulin therapy in chronic progressive lumbosacral plexopathy. Neurology. 44:1994;248-250.
22. Thomas P.K., Claus D., Jaspert A., Workman J.M., King R.H.M., Larner A.J., et al. Focal upper limb demyelinating neuropathy. Brain. 119:1996;765-774.
23. Midroni G., Dyck P.J. Chronic inflammatory demyelinating polyradiculoneuropathy: unusual clinical features and therapeutic responses. Neurology. 46:1996;1206-1212.
24. Thomas P.K., Walker R.W.H., Rudje P., Morgan-Hughes J.A., King R.H.M., Jacobs J.M., et al. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain. 110:1987;53-76.
25. Mendell J.R., Kolkin S., Kissel J.T., Weiss K.L., Chakeres D.W., Rammohan K.W. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 37:1987;1291-1294.
26. Rubin M., Karpati G., Carpenter S. Combined central and peripheral myelinopathy. Neurology. 37:1987;1287-1290.
27. Oh S.J. The `amyotrophic lateral sclerosis form' of chronic inflammatory demyelinating polyneuropathy. Ann. Neurol. 28:1990;269.
28. Waddy H.M., Misra V.P., King R.H.M., Thomas P.K., Middleton L., Ormerod I.E.C. Focal cranial nerve involvement in chronic inflammatory demyelinating polyneuropathy: clinical and MRI evidence of peripheral and central lesions. J. Neurol. 236:1989;400-405.
29. Kuwabara S., Nakajima M., Matsuda S., Hattori T. Magnetic resonance imaging at the demyelinative foci in chronic inflammatory demyelinating polyneuropathy. Neurology. 48:1997;874-877.
30. Morgan G.W., Barohn R.J., Basan I.I.I., King R.B., Klueznik R.P. Nerve root enhancement with MRI in inflammatory demyelinating polyneuropathy. Neurology. 43:1993;618-620.
31. Crio P.B., Grossman R.I., Rostami A. Magnetic resonance imaging of the cauda equina in chronic inflamatory demyelinating polyneuropathy. Ann. Neurol. 33:1996;311-313.
32. Ropper A.H. Further regional variants of acute immune polyneuropathy: bifacial weakness or six nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch. Neurol. 51:1994;671-675.
33. Kaji R., Shibasaki H., Kimura J. Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology. 42:1992;506-509.
34. Stewart J.D., McKelvey R., Durcan L., Carpenter S., Karpati G. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics. J. Neurol. Sci. 142:1996;59-64.
35. Barreira A., Marques W., Flores-Vieira C., Burgos F., Oliveira A. Chronic inflammatory demyelinating polyneuropathy with only sensory symptoms (CIDPS): electrophysiological and morphological aspects and association with diabetes mellitus. Proc. Periph. Nerve. Soc. 1997;115.
36. Felig P., Bergman M. The endocrine pancreas: diabetes mellitus. Felig P., Baxter J., Frohman L.A., Endocrinology and metabolism. 3rd ed. 1995;1107-1250 McGraw-Hill.
37. Sensi M., Pricci F., Andreani D., Di Mario U. Advanced non-enzymatic glycation endproducts: their relevance to aging and the pathogenesis of late diabetic complications. Diabetes Res. 16:1991;1-9.